GE HealthCare Inc.

GE HealthCare is a diversified multinational medical technology and digital solutions company with over 130 years of healthcare innovation history. The company develops and manufactures a broad portfolio of diagnostic imaging equipment, patient monitoring devices, anesthesia delivery systems, maternal and infant care solutions, and clinical consumables. Key product categories include CT scanners (including the recently FDA-cleared Photonova™ Spectra photon-counting CT), ultrasound systems, diagnostic ECG equipment, anesthesia machines, and contrast media. GE HealthCare operates globally with an installed base exceeding 5 million units and serves approximately 1 billion patients annually. The company has invested over $5.1 billion in R&D and product development since 2022 and leads the FDA's list of AI-enabled medical device authorizations with 110+ clearances. GE HealthCare offers integrated digital solutions including PACS, cloud-first enterprise platforms (as evidenced by the Intelerad acquisition), and clinical decision support software. The company holds FDA 510(k) clearances, CE marking, and other regulatory credentials across its device portfolio. Manufacturing, service, and support capabilities span multiple continents, supporting hospitals, healthcare systems, and clinical facilities worldwide.